Topic Listing for Bruker BioSciences

Accompanying Notes Integral Part Statements Accounting Stock Based Compensation
Accounting Stock Issued Employees Accounting Uncertainty Income Taxes
Accounting Uncertainty Income Taxes Interpretation Fasb Statement 109 Accounts Receivable
Accrued Expenses Other Liabilities Accrued Interest Fees Respect Thereof Include Appropriately Lenders
Accurately Records Name Address Each Person Owning Techneon Acquisition
Acquisition Bruker Biospin Acquisition Bruker Biospin Group Companies
Acquisition Bruker Optics Acquisition Further Strengthens Industrial Analysis Business Bruker Axs
Acquisition Related Charges Acquisition-related Charges
Acquisition-related Charges Credits Net Acquisitions
Activities Amendment Fasb Statement 133 Added Only Consent Required Terms Credit Agreement
Addition Each Borrower Shall Pay Other Taxes Related Addition Risks Applicable Life Science Materials Analysis Products
Addition Risks Applicable Life Science Products Nbc Detection Additional Agreements Collaborations Sales
Additional Conditional Price Additional Indemnity Addition Without Regard Limitations Indemnification Provided
Additional Information Find Administrative Agent Shall Received Copy Fairness Opinion Relating
Advent Euro-italian Direct Investment Program Limited Partnership Pggm Advent Global Gecc Limited Partnership
Advent International Advent Partners Limited Partnership Gpe
Advertising Advertising Costs
Affiliation Stockholders Affinium Pharmaceuticals Inc
Affirmative Covenants Against Techneon Amount 12827277310 Recorded Seller Financial Statements
Aggregate Option Exercises Last Values 2004 Agree Writing Take Foregoing Actions
Agreed Agreed Share Name Portions Intellectual Property Rights Distribution
Agreement Been Duly Authorized Executed Delivered Agreement Shares Fully Paid Nonassessable Other Restrictions Transfer
Agrees Pay Administrative Agent Own Account Fees Payable Allowance Doubtful Accounts
Alternate Rate Interest Prior Commencement Period Eurocurrency Amend Modify Violate Terms Transferred Contracts
Amendment Agilent Bruker Itms Collaboration Agreement Oem 2005 Amendment Agreement Amended Parties Hereto Time Execution Instrument
Amount Tax Saving Such Particular Reduction Burden Increase Amounts Shall Paid Wire Transfer
Amtsgericht Analytical X-ray
Annexes Annual Base Salary
Annual Cash Incentive Award Annual Cash Incentive Awards
Annual Salaries Applicable Law
Applicable Law Language Contract Application Clauses
Approval Modification Order Each Environmental Permit Continue Valid Approval Swiss Transactions Holders Shares Brkr Stock Representing
Armed Hostilities Constrain Ability Conduct Business Internationally Also Asset Allocations Category
Asset Purchase Agreement Assignment
Assumed Liabilities Shall Meaning Set Forth Attributable Defect Bug Breakdown Other Failure Deficiency Part
Audit Committee Audit Committee Pre-approval Policies Procedures
Audit Committee Report Audit Fees
Audit Related Fees Audit-related Fees
Auditors Fees Authority Committee
Authorization Effect Agreement Authorization Enforceability
Available Information Avoidance Clause
Background Transfer Background X-ray Microanalysis Market
Balance Sheet Cash Flow Baltic Scientific Instruments Ltd Acquisition
Basic Price Bbb Transferred Contracts Means Those Listed Schedule Including
Been Destruction Damage Loss Acquired Assets Been Threatened Knowledge Other Party Such Contract Agreement
Beneficial Ownership Reporting Compliance Bernhard Wangler
Bill Knight Bruker Biosciences Corporation Cfo Bill Knight-
Billerica 01821 Billerica Massachusetts 2006
Billerica Massachusetts 2007 Biographies
Bioscience Bioscience Segment
Bioscience Segment Revenues Biospin
Biospin Segment Biospin Segment Revenues
Blank Check Preferred Stock Board Committees Meetings
Board Directors Recommends Vote Ratification Appointment Ernst Young Board Directors Shareholders Bruker Biosciences Corporation
Board Meetings Committees Compensation Breach Nonfulfillment Covenant Agreement Part Sellers Target Respect
Breach Violation Corporate Documents Target Companies Subsidiaries Brenda Furlong
Brian Monahan Brian Monahan Corporate Controller
Brkr Brkr Shall Deliver Following Documents Deliverables Each Seller
Brkr Shall Deliver Following Escrow Agent Brkr Shall Entitled Recover Losses Indemnity Escrow Provided
Brkr Stock 558m Estimated 104m Shares Bruker Announces Management Promotions Strong 2009 Preliminary Operating
Bruker Axs Bruker Axs 2002 Restructuring Plan
Bruker Axs Acquire X-ray Analysis Software Socabim Bruker Axs Aftermarket
Bruker Axs Announces Acquisition Hand-held Xrf Bruker Axs Announces Agreement Acquire Princeton Gamma-tech Pgt
Bruker Axs Announces Agreement Acquire X-ray Microanalysis Roentec Bruker Biosciences
Bruker Biosciences 2003 Restructuring Plan Bruker Biosciences Announces Closing Acquisition Optics
Bruker Biosciences Announces Filing S-3 Registration Statement Bruker Biosciences Announces Preliminary 2006 Financial Results
Bruker Biosciences Combined Results Operations Including Optics Bruker Biosciences Corporation
Bruker Biosciences Corporation Exact Name Registrant Specified Charter Bruker Biosciences Corporation Form 8-k Index
Bruker Biosciences Corporation Manning Road Billerica 01821 978 Bruker Biosciences Corporation Notice Annual Meeting Stockholders
Bruker Biosciences Corporation Proxy Card Bruker Biosciences Corporation Proxy Statement
Bruker Biosciences Nasdaq Brkr Bruker Biosciences Non-affiliated Shareholders Overwhelmingly Approve Acquisition Biospin
Bruker Biosciences Report Material Weakness Internal Controls Request Bruker Biosciences Reports 113 Revenue Growth Improved Operating
Bruker Biosciences Reports 2007 Year-over-year Pooled Revenue Growth Bruker Biosciences Reports Financial Results 2007
Bruker Biosciences Reports Improved 2006 Operating Results Net Bruker Biosciences Reports Record Revenue Earnings Full 2006
Bruker Biosciences Reports Revenue 858 Operating Income Net Bruker Biosciences Reports Revenue Growth Improved Operating Income
Bruker Biosciences Reports Revenue Growth Operating Income Net Bruker Biosciences Reports Significantly Improved Earnings Strong Revenue
Bruker Biosciences Reports Solid Revenue Growth Improved Earnings Bruker Biosciences Reports Strong Revenue Net Income Growth
Bruker Biosciences Results Operations Excluding Optics Bruker Biospin After Merger Brkr Intends Retain Significant
Bruker Biospin Also Leading Manufacturer Superconducting Magnets Required Bruker Biospin Always Operated Private Not Complete Financial
Bruker Biospin Group Always Operated Private Not Place Bruker Biospin Market Leader Long History Rather Strong
Bruker Biospin Operates Mature Market Achieved High Share Bruker Biospin Shall Issued Invest Received Stock Certificate
Bruker Biospin Subsidiary Operates Mature Market Achieved High Bruker Companies Really What Today Biospin Originally Founded
Bruker Corporation Bruker Corporation Announces Closing Acquisition Biospin Group
Bruker Corporation Announces Foreign Exchange Losses 2008 Bruker Corporation Annual Report Form 10-k Table Contents
Bruker Corporation Appoints William Knight Chief Operating Officer Bruker Corporation Nasdaq Brkr
Bruker Corporation Reports 2008 Financial Results Bruker Corporation Reports 2008 Results
Bruker Corporation Reports 2009 Financial Results Bruker Corporation Reports 2009 Results
Bruker Corporation Reports Financial Results Full 2008 Bruker Daltonics
Bruker Daltonics 2002 Restructuring Plan Bruker Daltonics Aftermarket
Bruker Nasdaq Brkr Bruker Optics
Bruker Optics Aftermarket Bruker Optics Customers Include
Bruker Optics Management Bruker Optics Margins Income
Bruker Physik Business
Business Harmed Collaborations Fail Advance Product Development Business Means Sellers X-ray Microanalysis Including
Business Overview Business Segment Information
Business Segments Buyer Necessary Appropriate Evidence Release Liens Set Forth
Buyer Shall Assume Portion Bulova Order Whether Renegotiated Buyer Shall Pay Seller Closing 10355 Representing Sellers
Cagr Calculation Damages Consequences Breach Warranties Representations
Calculation Earn-out-payments Calculation Indemnity Payments Amount Loss Indemnification Provided
Cancel Third-party Indebtedness Owed Cancel Third-party Indebtedness Owed Biospin
Cancel Third-party Indebtedness Owed Invest Cancel Third-party Indebtedness Owed Target Companies
Capital Leases Capitalization
Capitalization Biospin Capitalization Subsidiaries Other Interests
Cash Equivalents Cash Portion 388 914 Valuation Resents Approximately 425
Cautionary Statement Cautionary Statement Bruker Biosciences
Cautionary Statement Bruker Corporation Cengent Therapeutics
Certain Financial Information Incorporated Reference Prospectus Presented Basis Certain Information Regarding Directors Nominees
Certain Relationships Related Transactions Certain Relationships Related Transactions Director Independence
Certification Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act
Change Control Shall Occur Change Pricing Royalties Charged Customers Licensees Business
Changes Internal Control Over Financial Reporting Chemical Biological Radiological Nuclear Cbrn Detection
Chief Executive Officer Compensation Chief Executive Officer Maintains Relationships Various Affiliates Impact
Chief Executive Officer Senior Vice President Maintain Relationships Christopher Canavan
Citizens Bank Massachusetts Clinical Proteomics Metabolomics Markets Not Grow Expected Meet
Closing Common Stock Offering Closing Conditions
Closing Consideration Closing Shall Occurred
Code Ethics Code Means Internal Revenue 1986 Amended
Code Subsidiary Paid Properly Includible Income Such Collin Dsilva
Combined Financial Results Bruker Corporation Combined Leading Provider High-performance Scientific Instrumentation Analytical Solutions
Combined Leading Provider Molecular Analysis Solutions Life Science Comment Outlook
Comments Analysis Comments Outlook
Commit Make Capital Expenditure Fail Expenditures Consistent Past Commitment Heirs Vendors Liability
Commitments Contingencies Common Shares
Common Stock Common Stock Par Value
Compared 2002 Compared 2003
Compared 2004 Comparison Five-year Cumulative Total Returns Performance Graph Bruker
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Directors
Compensation Indemnification Agreement Competition
Competitive Strengths Strategy Complete Copies Federal State Local Foreign Tax Returns
Complete Copies Seller Delivered Available True Each Existing Complete Range Technology Shown Slide Not Take Through
Completion Acquisition Disposition Assets Compliance Certificate
Comply Rule 433 Act Without Reliance 164 Components Executive Compensation
Composition Committee Comprehensive Income
Comprehensive Income Loss Concentration Credit Risk
Conditions Conditions Closing
Confer Buyer Concerning Business Operational Matters Relating Significant Conference Call
Confidential Treatment Requested Bruker Biosciences Corporation Confidentiality
Connection Issuance Sale Shares Registration Statement Preliminary Prospectus Connection Resale Distribution Thereof Transaction Violation Applicable Laws
Consent Independent Auditors Consent Independent Registered Public Accounting Firm
Construction Contents
Contingencies Continuing Then Page Numerous Present Future Growth Markets
Contracts Listed Schedule Shall Been Amended Manner Reasonably Contribution Event Joint Liability
Contributions Payments Expenditures Gifts Violated Operated Noncompliance Export Controls Procedures
Conveyance Reorganization Moratorium Similar Laws Affecting Creditors Rights Corporate Information
Corporation Corporation Shall Not Imputed Director Purposes Determining Right
Corporations By-laws Currently Provides Members Board Directors Following Cost Revenue
Cost Sales Costs
Course Without Material Disruption Interruption Conduct Business Covenants
Covenants Agreements Cowen-analyst
Credits Critical Accounting Policies
Critical Accounting Policies Estimates Cumulative Effect Change Accounting Principle
Current Report Pursuant Securities Exchange Act 1934 Currently Offer Following Xrd Systems
Customer Advances Customer Deposits
Customer Deposits Advance Payments Received Subsidiary Ordinary Course Customers
Customers Here Again Primarily Academia Particular Medical Schools Daniel Dross
Deal Structure Schedule Debt
Debt Adversely Affect Cash Flow Restrict Investment Opportunities Declarations Caussin François Cartier Julien Nusinovici
Declarations Purchaser Issuer Brkr Shares Defined Benefit Plans
Definitions Definitions Purposes Agreement
Deleted Deliveries Buyer Shall Delivered Seller Pgt-uk Principal Stockholders
Denominated Euro Bear Interest Adjusted Euribo Rate Period Departure Directors Certain Officers Election Appointment Compensatory
Departures Directors Principal Officers Election Appointment Compensatory Dependent Various Key Personnel Recruit Additional Qualified Number
Derik Bruin- Derivative Financial Instruments
Derivative Instruments Derivative Instruments Hedging Activities
Derivative Work Meaning Ascribed United States Copyright Law Derive Significant Portion Revenue International Sales Subject Risks
Description Business Description Business Basis Presentation
Description Transaction Basis Presentation Determination Entitlement Indemnification Independent Legal Counsel Pursuant Hereof
Determined Biospin Brkr Sellers Necessary Desirable Expedient Further Director Nominations
Directors Continuing Office Until 2006 Annual Meeting Directors Continuing Office Until 2008 Annual Meeting
Directors Continuing Office Until 2009 Annual Meeting Directors Continuing Office Until 2010 Annual Meeting
Directors Executive Officers Corporate Governance Directors Executive Officers Registrant
Dirk Laukien Dirk Laukien Phd
Dirk Laukien Senior Vice President Disclosure Controls Procedures
Dispersive Raman Distribution
Dividends Documents Incorporated Reference
Dollars 40000000 Dsilva
Duly Revised Accurately Reflect Record Beneficial Ownership Shares Duties Purchaser
Duties Responsibilities Duties Responsibilities Committee
Duties Vendors Each Telephonic Written Interest Election Request Shall Specify
Earn-out-payments Earnings Conference Call
Earnings Per Share Effect Making Transactions Contemplated Hereby Illegal Otherwise Prohibiting
Effectuation Transactions Contemplated Hereby Shall Governed Terms Confidentiality Election Brkr Shall Time Make 338 Code
Eliminations Combined Balance Sheet Statements Operations Emerging Risk Liquid Helium Becoming Scarce Significantly Expensive
Employee Benefit Plans Employee Benefits
Employee Benefits Matters Employee Retirement Plans
Employee Shall Mean Current Former Retired Consultant Director Employees
Employees Techneon Employment Contracts Termination Change Control Arrangements
Encumbrance Restriction Including Put Call Arrangements Respect Transfer Encumbrance Stock Assets Otherwise Interest Corporation Partnership Other
Energy Supercon Technologies Segment Revenues Engage Hold Interest Own Manage Operate Control Direct
Entry Material Definitive Agreement Environmental
Equipment Customer Base Marketing Sales Service Documentation Databases Equipment Operating Leases
Equity Compensation Plan Information Equity Compensation Plans
Esi-tof Estimated Future Benefit Payments
Estimates Events Default
Events Termination Exact Name Registrant Specified Charter
Except Otherwise Set Forth Below Trade Names Used Except Required Result Change Applicable Law Gaap Accounting
Except Set Forth Schedule 419 Shares Subsidiaries Not Except Share Data
Exceptions Restriction Competition Exclusion Waiver
Exclusive Distributorship Executive Benefits
Executive Compensation Executive Compensation Philosophy
Executive Officers Executive Overview
Exhibits Existing Stockholders Significant Influence Over
Expenses Ending Date Such Payment Director Corporation Expenses Registration Duties
Explanatory Face Challenges Integration Result Lower Expected Synergies Merger
Face Potential Volatility Stock Price Face Substantial Competition
Factors Affecting Business Operating Results Financial Condition Factory Shift
Fail Maintain Assets Good Repair Condition Except Extent Fail Maintain Effective Systems Internal Controls Not Able
Failure Qualified Not Reasonably Expected Adverse Effect Target Fair Value
Fair Value Financial Instruments Financial Assets Liabilities Including Amendment Fasb Statement 115
Financial Condition Results Operations Consolidated Subsidiaries Basis Accordance Financial Covenants
Financial Information Geographic Areas Segments Financial Overview
Financial Results Financial Results Bruker Biosciences Excluding Biospin Group
Financial Statement Schedules Financial Statements
Financial Statements Businesses Acquired Financial Statements Exhibits
Financial Statements Other Information Furnish Administrative Agent Financial Statements Schedule
Financial Statements Supplementary Data Financial Statements Undisclosed Liabilities
Financing Arrangements Fixed Price
Foreign Currency Translation Foreign Currency Translation Transactions
Foreign Exchange Rate Risk Management Form 10-k
Form 10-q Form Pledge Amendment
Frank Laukien Phd Ft-ir
Ft-nir Ft-raman
Ftms Full 2007 Revenue Increased After Currency Adjustments 5476
Further Agreements Written Form Further Assurances Each Party Hereto Request Another Shall
Furthermore Present Guarantee Exercised Following Form Purchasers Discretion Future Sales Stock Impact Market Price
Geneprot Inc General
General Administrative General Adminstrative
General Assignment Shall Meaning Set Forth General Health Care Spending Patterns Decline Ability Generate
German Share Purchase Agreement German Share Purchase Agreement Bruker Physik Gmbh
Gesellschaften Global Recession Continues Hinder Growth
Goodwill Goodwill Intangible Assets
Goodwill Other Intangible Assets Goodwill Other Intangible Assets Investments Companies Long-lived
Goodwill Other Intangible Assets Long-lived Goodwill Other Intangible Assets Subject Impairment
Governing Law Parties Agree Agreement Shall Governed Construed Government Contracts
Government Regulation Governmental Authority Lenders Credit Facility Used Brkr Other
Grants Grants Plan-based Awards
Grants Stock Options Gross Margin Initiative 2006-2008
Guarantee Guarantees
Guarantees Indebtedness Subsidiary Other Health Care Reform Adversely Affect Revenue
Hereby Agrees Highlights
Highlights Revenue 311 Gaap Eps 013 Hire Employees Relating Business
Historical Pro-forma Eps Accretion 001-002 However
Immediately After Consummation Transactions Occur Effective Date Subsidiaries Impact Foreign Currencies
Impact Interest Rates Impairment Charges
Impairment Long-lived Assets Including Recently Acquired Bruker Biospin Group Combined 2007
Income Operations Income Tax Provision
Income Tax Provision Benefit Income Taxes
Increased Costs Change Law Shall Increasing Prices Metal Raw Materials Superconducting Wire Adversely
Ind Indebtedness Representing Deferred Compensation Employees Subsidiary Incurred Ordinary
Indebtedness Respect Swap Agreements Permitted 605 Indemnification Amounts
Indemnification Procedure Indemnification Proceeding Etc
Indemnification Tax Claims Indemnifications
Indemnifying Party Shall Meaning Set Forth Independent Registered Public Accounting Firm
Index Index Financial Statements
Indirectly Equity Interests Shares Capital Stock Other Voting Inflation
Information Current Report Form 8-k Including Information Current Report Form 8-k Including Exhibits Attached
Information Technology Information Technology Except Described Schedule
Insolvenzordung Competent Court Institutes Rejects Reason Insufficiency Funds Intangible Assets
Intellectual Property Intended Take Effect Sealed Instrument Obligations Borrower Hereunder
Interest Other Income Expense Net Interest Premium Payable Terms Such Obligations Thereon Other
Interest Rate Risk Management Internal Control-integrated Framework
Inventories Inventory Pricing
Invest Foreign Corporation Within Meaning 7701 Code Invest Shareholders Brkr
Investments Borrowers Existing Date Hereof Capital Stock Subsidiaries Investments Other Companies
Involved Lawsuits Protect Enforce Patents Brought Expensive Time Irs Shall Mean Internal Revenue Service
Issuance Restricted Stock Issuer Purchases Equity Securities
Itms Joerg Laukien
Jurisdiction Kniss
Labor Relations Land Register Extract Per Schedule True Complete Correct
Last Not Least Think Theres Additional Opportunity Operational Leading Provider Molecular Spectroscopy Tools Solutions
Leased Real Property Constitutes Necessary Conduct Biospin Uss Legal
Legal Proceedings Legal Proceedings General
Legal Succession Assignment Let Start Transaction Overview Rationale Remind Everybody Subject
Letters Credit Guarantees Level
License Agreements Liens Arising Out Conditional Sale Title Retention Consignment
Liens Assets Subsidiaries Not Otherwise Permitted Above Long Liens Attaching Commodity Trading Accounts Brokerage Incurred Ordinary
Limitation Limitation Disposal Brkr Shares
Limitation Liability Limitations
Line Credit Linton
Liquidate Dissolve Recapitalize Otherwise Wind Business Liquidity Capital Resources
List Definitions List Exhibits
List Schedules Long-lived Assets
Long-term Debt Long-term Incentives
Lose Money Exchange Foreign Currency Received International Sales Lose Strategic Partners Marketing Efforts Impaired
Loss Losses Shall Meanings Set Forth Mac Science Ltd
Maintain Books Records Usual Regular Ordinary Manner Basis Majority Voting Non-affiliated Brkr Shareholders
Maldi-tof Management
Management Promotions Effective 2010 Managements Discussion Analysis Financial Condition Results Operations
Managements Report Internal Control Over Financial Reporting Manning Road Billerica 01821
Manning Road Billerica 01821 Address Principal Executive Offices Manufacture Sale Products Lead Product Liability Claims Substantial
Manufacturing Supplies Market Prices
Market Registrants Common Equity Related Stockholder Matters Issuer Marketing Advertising
Material Definitive Agreements Material Payment Benefit Manager Officer Employee Consultant Independent
Material Provision Loan Document Reason Ceases Valid Binding Materials Research
Meetings Meetings Committee
Membership Structure Minority Interest Consolidated Subsidiaries
Miscellaneous Miscellaneous Provisions
Multiemployer Plan Means Pension Defined Erisa Mutual Written Consent Duly Authorized Buyer Seller
Name Necessary Appropriate Registration Statement Pursuant Rule 462 Act
Necessary Desirable Effecting Completely Consummation Agreement Transactions Contemplated Negative Covenants
Neither Biospin Nor Subsidiaries Granted Power Attorney Person Neither Biospin Nor Subsidiary Ever Participated International Boycott
Neither Biospin Nor Subsidiary Owns Real Property Neither Nor Subsidiaries Granted Power Attorney Person Respect
Neither Nor Subsidiary Party Subject Law Regulation Rule Neither Seller Nor Principal Stockholders Pgt-uk Mortgaged Pledged
Neither Target Companies Nor Subsidiaries Granted Power Attorney Net Income
Net Income Attributable Bruker Corporation Net Income Attributable Noncontrolling Interests
Net Income Loss Net Income Loss Attributable Bruker Corporation
Net Income Loss Attributable Noncontrolling Interests Net Sales
New Accounting Pronouncements New Product Cycle Fed 2007 Growth Accelerated
New Technologies Product Developments Not Succeed Nominee Election One-year Term Expiring 2006 Annual Meeting
Nominees Nominees Election Three-year Term Expiring 2008 Annual Meeting
Nominees Election Three-year Term Expiring 2010 Annual Meeting Nominees Election Three-year Term Expiring 2011 Annual Meeting
Non-competition Clause Non-gaap Financial Measures
Non-gaap Operating Income Net Eps Q1-06 Exclude Acquisition Noncontrolling Interests
Not Able Maintain Sales Service Staff Meet Demand Not Nor Permit Subsidiaries Change Basis Effect Effective
Not Realize Anticipated Benefits Global Stimulus Packages Not Result Creation Imposition Lien Asset Subsidiaries Other
Notes Consolidated Financial Statements 1-description Business Notification
Notification Claims Notification Disclosure Parties
Notifications Notwithstanding Other Provision Agreement Borrower Shall Entitled Request
Nuclear Biological Chemical Nbc Detection Number
Number 000-30833 Obligations Other Indebtedness Created Loan Documents
Occurrence Default Oes
Oes-spark Optical Emission Spectroscopy Metals Analysis Xrd Omissions
Operating Businesses Operating Leases
Operating Principles Operation Between Date Agreement Closing Unless Otherwise Agreed
Operations Dependent Limited Number Suppliers Contract Manufacturers Operations Seller Pgt-uk Not Been Terminated
Operator Opinion Buyer Shall Received Satisfactory Legal Counsel Seller
Option Grants Orderly
Orders Performance Organization Buyer Corporation Duly Organized Validly Existing Good
Organization Seller Subsidiaries Other Pgt-uk Other
Other Acquisitions Other Benefit Plans
Other Companies Difficulty Acquiring Even Doing Benefit Stockholders Other Comprehensive Income Loss
Other Current Liabilities Other Development Results Reasonably Expected Result Material Adverse
Other Events Other Fees
Other Income Expense Net Other Information
Other Matters Other Named Executive Officer Compensation
Other Obligations Issue Rights Convert Obligation Shares Capital Other Plans
Other Provisions Other Rights Indemnification Insurance
Other Similar Agreements Understandings Respect Equity Interests Subsidiaries Other Systems Revenue
Overview Overview Bruker Biospin Group
Overview Presentation Ownership Enjoyment
Part Parties Desire Set Forth Certain Additional Agreements They
Partnership Other Person Assets Comprising Business Property Single Pay Perform Other Obligations Business Due
Payment Basic Price Payment Purchase Price Due Date
Payments Generally Pro Rata Treatment Sharing Set-offs Pension Plan Means Each Seller Employee Benefit Within
Performance Graph Period Not Adequately Fairly Reflect Cost Such Lenders
Periods Prior Closing Date Been Paid Target Companies Permits Compliance Law
Permitted Encumbrances Liens Created Pledge Agreements Perquisites
Pharma Biotech Pat Process Analytical Technologies Pharma-forensics Fake Drug Analysis
Place Jurisdiction Plan Significant Future Growth Risk Not Able Manage
Plan Significant Growth Risk Not Able Manage Please Vote Date Sign Return Promptly Enclosed Envelope
Pledged Capital Stock Pledged Membership Interests
Pledged Partnership Interests Policies
Practicable After Termination Such Twelve-month Period Not Later Pre-approval Policies Procedures
Preamble Preemptive Similar Rights Issued Compliance Applicable Federal State
Preliminary Operating Highlights Prepayment Loans
Price Payment Pricing Common Stock Offering
Principal Accountant Fees Services Principal Accounting Fees Services
Principles Consolidation Prior Agreements
Pro Forma Adjustments Condensed Combined Balance Sheet Pro Forma Adjustments Condensed Combined Statements Operations
Pro Forma Condensed Combined Financial Statements Pro Forma Financial Information
Pro-forma Combined Financials Give Effect Acquisition Had Been Procedures
Procedures Actions Signing Agreement Procedures Approval Transactions Related Persons
Proceeds Registered Securities Process Schedule
Products Compete Markets Subject Rapid Technological Change Most Products Compete Markets Subject Rapid Technological Change Technologies
Products Fail Achieve Sustain Sufficient Market Acceptance Across Products Regulated Restricted Addressed Applicable Environmental Law
Prolonged Downturn Global Economic Conditions Materially Adversely Affect Promptly Following Receipt Interest Election Request Administrative Agent
Properties Property Plant Equipment
Proposal Ratification Independent Registered Public Accounting Firm Proprietary Rights
Proration Taxes Other Fees Payments Arising Connection Acquired Provided However
Provision Benefit Income Taxes Provision Income Taxes
Proxy Statement Accompanying Annual Report Available Via Internet Pto Means United States Patent Trademark Office
Public Offering Common Stock Public Offerings Common Stock
Purchase Price Purchase Sale
Purchase Sale Interests Closing Purchase Sale Shares Closing
Purchaser Purchaser Cannot Claim Against Vendors Contract Loss Whose
Purchaser Registration Shares Purchasers Shareholders Account Purchaser Shall Deliver Following Documents Deliverables Each Seller
Purchaser Trailing Average Less 311 Purchasers
Purchasers Shall Entitled Recover Losses Indemnity Escrow Provided Purchases Sales
Purpose Committee Purpose Philosophy
Quantitative Qualitative Disclosures Market Risk Quarterly Financial Data
Quarterly Period 2008 Quarterly Period 2009
Real Property Leases Reasonable Best Efforts
Receipt Recent Accounting Developments
Recent Accounting Pronouncements Recent Sales Unregistered Securities
Recitals Reclassification
Reclassifications Record Date Voting Securities
Redeemable Preferred Stock Reduction Capital Resources Government Funding Customers Reduce Sales
Register Techneon Duly Revised Reflect Record Beneficial Ownership Registration Statement Excluding Exhibits Thereto Each Preliminary Prospectus
Regulation Disclosure Related Parties
Related-party Transactions Relationship Parties
Release Bank Securities Reliable Accurate Obtained Written Consent Such Data Sources
Remediation Steps Address Material Weaknesses Remediation Steps Addressed Material Weaknesses Identified 2004
Repayment Purchase Price Repayments Principal
Report Audit Committee Report Independent Auditors
Report Independent Registered Public Accounting Firm Report Independent Registered Public Accounting Firm Internal Control
Reported Financial Results Adversely Affected Fluctuations Currency Exchange Reports Profitable Cash Flow Operations 2005
Representations Warranties Representations Warranties Brkr
Representations Warranties Buyer Representations Warranties Invest Shareholders
Representations Warranties Merger Sub Representations Warranties Purchaser
Representations Warranties Purchasers Representations Warranties Regarding
Representations Warranties Regarding Biospin Representations Warranties Regarding Target Companies
Representations Warranties Seller Pgt-uk Principal Stockholders Representations Warranties Sellers
Representations Warranties Shall Survive Remain Full Force Effect Research Development
Responding Claims Relating Improper Handling Storage Disposal Hazardous Restatement Financial Statements
Restricted Cash Restructuring Activities
Restructuring Charges Resulting Combined
Results Operations Results Operations Financial Condition
Revenue Revenue Recognition
Reversal Liability Accrual Review Approval Ratification Transactions Related Persons
Review Performance Incentive Compensation Revised Tax Assessment Having Sole Effect Transferring Charge
Richard Kniss Richard Packer
Richard Stein Risk Factors
Rule 14a-101 Röntec Gmbh
Safe Harbor Statement Brkr Sale Transfer Shares
Sale Transfer Silent Partnership Interests Sales
Sales Cycle Sales Marketing
Same Originating Cause Harm Cannot Way Entertained Once Sarbanes-oxley Act 2002
Scd Schedule
Schedule 14a Schedules Filed 2005 Form 10-k
Scientific Instruments Scientific Instruments Segment Revenues
Scitec Real Property Not Located Area Seasonal Nature Business
Sec Filings Securities Act Means United States 1933 Amended
Security Ownership Certain Beneficial Owners Management Security Ownership Certain Beneficial Owners Management Related Stockholder
See Accompanying Notes See Accompanying Notes Financial Statements
Segment Information Segments Geographic Information
Seller Shall Deliver Following Documents Deliverables Purchasers Sellers
Sellers Brkr Sellers Purchaser
Sellers Purchasers Sellers Rights
Sellers Shall Deliver Following Documents Deliverables Brkr Sellers Shall Deliver Following Documents Deliverables Purchaser
Sellers Shall Deliver Following Documents Deliverables Purchasers Services
Set-off Severability Clause
Shall Cooperate Connection Therewith Failure Purchaser Indemnified Parties Shall Disclosed Lenders Prior Effective Date Otherwise Satisfactory
Shall Not Occurred Since Date Hereof Events Had Share
Share Capital Share Transfer Deed
Share-based Payment Sharing Agreement
Shipping Handling Costs Short-term Investments
Signatures Since 2006 Been Material Adverse Change Business Assets
Small Shareholders Snapshot
Software Costs Solicitation
Solvency Special Charges
Special Meeting Brkr Stockholders Held 2008 Specifying Reasonable Detail Such Claimed Default Breach Inaccuracy
Spencer Nam- Statements Been Prepared Accordance Books Records Consistent Past
Stock Compensation Arrangements Stock Incentives
Stock Option Exercises 2004 Values Stock Option Exercises 2005 Values
Stock Options Stock Plans
Stock Price Performance Graph Stock Purchase Agreement
Stock Purchase Agreement Bruker Biospin Inc Stock Repurchase Programs
Stock-based Compensation Stockholder Communications
Stockholders Also Able Obtain Copy Definitive Proxy Statement Subject Event Termination Abandonment German Spa Pursuant Shall
Subject Existing Potential Additional Regulation Government Inquiry Impose Subject Existing Potential Additional Regulation Impose Burdens Operations
Subject Provisions Failure Discharge Obligation Notify Inform Vendors Subject Rules Law Governing Specific Performance Injunctive Relief
Subject Satisfaction Prior Closing Date Following Conditions Waived Submission Matters Vote Security Holders
Subsequent Events Subsidiaries Agents Other Affiliates Concerning Alternative Proposal Sellers
Subsidiary Shall Become Unable Admit Writing Inability Fail Success Depends Ability Operate Without Infringing Misappropriating Proprietary
Summary Compensation Table Summary Executive Compensation
Suppliers Capital Spending Government Funding Policies Changes Governmental Survival Indemnification
Swiss Agreement Plan Merger Swiss Closing Shall Occurred
Swiss Merger Agreement Table Contents
Take Action Impair Encumber Create Lien Against Otherwise Tangible Assets
Target Companies Foreign Corporations Within Meaning 7701 Code Tax Fees
Tax Fees Ernst Young Llp Tax Matters
Tax Taxes Shall Meanings Set Forth 413 Taxes Tax Returns Except Provided Schedule
Taylor Crouch Techneon
Term Agreement Termination
Termination Amendment Waiver Termination Material Definitive Agreement
Terms Conditions Terms Covenants Conditions Complied Performed Purchasers Prior Closing
Terms Covenants Conditions Complied Performed Sellers Prior Closing Thereby Entitled Brokers Finders Fee Other Similar Connection
Time Immediately After Giving Effect Such Borrowing Issuance Time Submission Stockholder Proposals
Tony Butler Lehman Brothers Analyst Transactions Related Parties
Transactions Related Persons Transfer
Transformed Sas Unable Effectively Protect Intellectual Property Parties Technology Impair
Unable Integrate Successfully Businesses Bruker Biospin Combined Not Unable Integrate Successfully Businesses Bruker Biospin Group Combined
Unable Make Complete Future Mergers Acquisitions Strategic Alliances Unable Make Successful Acquisitions Part Growth Strategy Integrate
Unable Recover Significant Development Costs Products Product Lines Undisclosed Dividend Distributions Been Target Companies Subsidiaries Before
Unpredictability Fluctuation Quarterly Results Adversely Affect Trading Price Unregistered Sales Equity Securities
Unregistered Sales Equity Securities Proceeds Unremedied Period After Notice Thereof Administrative Agent Given
Unresolved Staff Comments Used German Spa Following Terms Shall Meanings
Various International Tax Risks Adversely Affect Earnings Vendors Liable Make Good Only Net Loss Effectively
Vertex 80v High-resolution Vacuum Research Ftir Violate Conflict Organizational Document Brkr
Violate Conflict Organizational Document Purchaser Violate Conflict Organizational Document Purchasers
Violate Conflict Result Breach Organizational Document Violate Conflict Result Breach Organizational Document Biospin
Vote Directors Vote Proposals
Voting Proxies Warranty
Warranty Concerning Site Warranty Costs
Warranty Costs Deferred Revenue William Knight
William Knight Chief Financial Officer William Linton
Wolf-dieter Emmerich Phd Working Capital Adjustment
Working Capital Requirements Wwwbruker-biosciencescom
Xrd Xrf
Xvi Maintain Transfer Agent Necessary Jurisdiction Incorporation Registrar 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki